Omega Diagnostics Group PLCODX:LSE

14.00
0.25 / 1.75 %
44.14k
6.67%
1.06
Close in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Nov 21 2014 15:29 GMT.
ODX:LSE is traded on the London Stock Exchange Alternative Investment Market (Aim)

Directors & officers

 NameTitleCompensationAgeOfficer
since
 
DavidEvans
Independent Non-Executive Chairman of the Board
25.00k GBP
53
2006
Mr. David E. Evans, CA, is an Independent Non-Executive Chairman of the Board of Omega Diagnostics Group Plc. He has experience within the diagnostics industry. As Financial Director he was a key member of the team that floated Shield Diagnostics Limited in 1993. He became Chief Executive Officer responsible for the merger of Shield Diagnostics Group plc with Axis Biochemicals ASA of Norway in 1999 to create Axis-Shield plc. In addition to his role as Non-executive Chairman of Omega, he holds Non-executive Directorships in a number of other companies.
 
AndrewShepherd
Chief Executive, Managing Director, Executive Director
145.00k GBP
--
2007
 
KieronHarbinson
Group Finance Director, Company Secretary, Executive Director
116.56k GBP
--
2002
 
IainLogan
Group Financial Controller
--
--
2010
 
JagGrewal
Group Sales and Marketing Director, Executive Director
110.00k GBP
--
2011
 
KarstenBrenzke
Site Manager of Omega Diagnostics GmbH
--
--
2012
 
MikeGordon
Group Operations Director
--
--
2011
 
PrashantManiar
Managing Director of Omega Dx (Asia) Pvt Limited
--
--
2011
 
EdwardValente
Group Research and Development Director
--
--
2011
 
JamieYexley
Site Manager of Genesis Diagnostics Limited and Cambridge Nutritional Sciences Limited
--
--
2012
 
WilliamRhodes
Non-Executive Director
--
58
2013
View all 11 directors & officersOfficers and Directors data as of Nov 23 2014

Director dealings

Directors have been net buyers of Omega Diagnostics Group PLC shares during the last thirty-six months, indicating that they are confident in the prospects for their company in the future.

As of 01 Nov 2014
Mouseover chart for details.
There are no recent director transactions available.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.